Lausvig, Nanna Leonora
University of Copenhagen · Novo Nordisk (Denmark) · University of Washington · UNSW Sydney · University of Chicago · Steno Diabetes Center Copenhagen
3 papers on CoChat
Most cited papers
- Verified
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Perkovic, V., Tuttle, K. R., Rossing, P., Mahaffey, K. W., Mann, J. F. E., Bakris, G., Baeres, F. M. M., Idorn, T., Bosch-Traberg, H., Lausvig, N. L., et al. (2024) · New England Journal of Medicine
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 2,099
- Verified
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
Lingvay, I., Catarig, A.-M., Frias, J. P., Kumar, H., Lausvig, N. L., le Roux, C. W., Thielke, D., Viljoen, A., & McCrimmon, R. J. (2019) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 298
- Verified
Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
McCrimmon, R. J., Catarig, A.-M., Frias, J. P., Lausvig, N. L., le Roux, C. W., Thielke, D., & Lingvay, I. (2020) · Diabetologia
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 184
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free